NCT01169584: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients |
|
|
| Completed | 1 | 6 | US | Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594), Pexa-Vec | Jennerex Biotherapeutics, Solving Kids' Cancer | Neuroblastoma, Rhabdomyosarcoma, Lymphoma, Wilm's Tumor, Ewing's Sarcoma | 03/12 | 11/14 | | |